Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
AKRO
Live
Save
Overview
Financials
Filings
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -4.7%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
akero
therapeutics
phase
mash
nasdaq
offering
patients
study
potential
results
efruxifermin
metabolic
announced
firm
2024
liver
harmony
trial
symmetry
stage
A
AKRO
Stonvex
StonvexStonvexStonvexStonvex